TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.
In cancer patients, plasma often contains mutant DNA released by cancer cells. We have assessed the significance of plasma DNA mutations for subsequent cancer development in healthy subjects in a large longitudinal prospective study. The European Prospective Investigation into Cancer and Nutrition s...
Prif Awduron: | Gormally, E, Vineis, P, Matullo, G, Veglia, F, Caboux, E, Le Roux, E, Peluso, M, Garte, S, Guarrera, S, Munnia, A, Airoldi, L, Autrup, H, Malaveille, C, Dunning, A, Overvad, K, Tjønneland, A, Lund, E, Clavel-Chapelon, F, Boeing, H, Trichopoulou, A, Palli, D, Krogh, V, Tumino, R, Panico, S, Bueno-de-Mesquita, H |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2006
|
Eitemau Tebyg
-
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: A prospective study
gan: Gormally, E, et al.
Cyhoeddwyd: (2006) -
Amount of DNA in plasma and cancer risk: a prospective study.
gan: Gormally, E, et al.
Cyhoeddwyd: (2004) -
Amount of DNA in plasma and cancer risk: A prospective study
gan: Gormally, E, et al.
Cyhoeddwyd: (2004) -
DNA adducts and lung cancer risk: A prospective study
gan: Peluso, M, et al.
Cyhoeddwyd: (2005) -
DNA adducts and lung cancer risk: a prospective study.
gan: Peluso, M, et al.
Cyhoeddwyd: (2005)